Saturday, August 23, 2025 5:22:29 PM
I really hope we get the approval in the next few weeks—or at least that Linda believes it’s coming, assuming she sold her house to help fund the company in a time of need. If that’s true, then her move deserves real respect. But if not, this $4–5 million won’t last more than a month, and they’ll be back in the same position again.
The MHRA is taking forever—it’s honestly so frustrating.
Hearing about Les Goldman’s passing really hit me hard. It wasn’t just the loss itself—it was knowing he spent the last 12 years dedicated to this company, holding onto hope and working toward an outcome he, sadly, never got to witness. I felt a similar sense of loss when Joan Lappin passed. At a certain point in life, it’s no longer just about money—there’s a deeper fulfillment that comes from achieving a goal or making a difference in others’ lives.
The MHRA is taking forever—it’s honestly so frustrating.
Hearing about Les Goldman’s passing really hit me hard. It wasn’t just the loss itself—it was knowing he spent the last 12 years dedicated to this company, holding onto hope and working toward an outcome he, sadly, never got to witness. I felt a similar sense of loss when Joan Lappin passed. At a certain point in life, it’s no longer just about money—there’s a deeper fulfillment that comes from achieving a goal or making a difference in others’ lives.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
